BIOMAT Database Logo BIOMAT Database Logo

[Cerebral NE and DA levels after chronic treatment with nomifensine]. 1980

L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D009627 Nomifensine An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266) Hoe-984,Linamiphen,Merital,Nomifensin,Nomifensine Maleate,Nomifensine Maleate (1:1),Hoe 984,Hoe984,Maleate, Nomifensine
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
Decrease in brain NE turnover after chronic DMI treatment; no effect with iprindole.
April 1978, Psychopharmacology,
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine.
October 1997, Molecular pharmacology,
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
State of DA/ACh balance after chronic treatment with haloperidol and with THIP in rats.
January 1984, Advances in neurology,
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
Treatment of bulimia with nomifensine.
March 1986, The American journal of psychiatry,
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
Successful treatment of bulimia with nomifensine.
March 1986, The American journal of psychiatry,
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
[Treatment of depressive conditions with nomifensine].
October 1979, Activitas nervosa superior,
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
Paranoid symptoms after nomifensine.
August 1982, Lancet (London, England),
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
Paranoid symptoms after nomifensine.
October 1982, Lancet (London, England),
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
[Hemolytic anemia with kidney failure after nomifensine].
June 1986, Deutsche medizinische Wochenschrift (1946),
L Ravizza, and F Bogetto, and E Torre, and P Rebaudengo
Treatment of cerebral ischemia with Dextran-40 or Fluosol DA 20%.
January 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology,
Copied contents to your clipboard!